Register entry

Chongqing Biocare Pharmaceutical Ltd.

Registered sites
1
Drug products
15
Live patents
0
Countries
1
Base
China
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Active ingredient (API) manufacture
Sites

Facilities

1
SiteLocationOperationsFEI
Chongqing Biocare Pharmaceutical Ltd.ChongqingChinaActive ingredient (API) manufacture3006305268
Catalogue

Marketed products

15

Showing 15 of 15.

BrandGeneric nameFormCategory
-ChlorothiazidePOWDERBULK INGREDIENT
-ClevidipinePOWDERBULK INGREDIENT
-Clindamycin PalmitatePOWDERBULK INGREDIENT
-Dasatinib AnhydrousPOWDERBULK INGREDIENT
-Dexmedetomidine hydrochloridePOWDERBULK INGREDIENT
-DexrazoxanePOWDERBULK INGREDIENT
-Epinastine HydrochloridePOWDERBULK INGREDIENT
-Epinastine HydrochloridePOWDERBULK INGREDIENT
-Eribulin MesylatePOWDERBULK INGREDIENT
-Fludarabine PhosphatePOWDERBULK INGREDIENT
-Lapatinib Ditosylate MonohydratePOWDERBULK INGREDIENT
-PhytonadionePOWDERBULK INGREDIENT
-Phytonadione 2 IsomerLIQUIDBULK INGREDIENT
-Sodium SalicylatePOWDERBULK INGREDIENT
-Trehalose dibehenatePOWDERBULK INGREDIENT
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.